Early Intervention: Better Clinical and Economic Outcomes

2018-05-09T18:26:10+00:00 May 9th, 2018|

by Phyllis Hanlon, Contributing Writer   Researchers who study WHO Group 1 PH (PAH, pulmonary arterial hypertension) have shown that drugs may delay progression of the disease, reduce symptoms and improve quality of life. More recently, scientists have found that using more than one drug early when a patient is newly diagnosed can produce an even

Diagnosing and Treating Older Patients with PH: A Complex Process

2018-05-09T18:01:42+00:00 May 9th, 2018|

by Phyllis Hanlon, Contributing Writer   In 2016, the Population Reference Bureau released a report that projects the number of people age 65 and older will more than double from 46 million currently to over 98 million by 2060. Age can bring many changes in health and physical conditions. According to the National Council on

Study Looks at HIV and Pulmonary Hypertension

2018-05-03T17:28:11+00:00 May 3rd, 2018|

by Phyllis Hanlon, Contributing Writer   Pulmonary hypertension, or high blood pressure in the lungs, has been associated with a number of different conditions including heart disease, liver disease, lupus and scleroderma. Research indicates that people with HIV are also at risk for developing PH, a serious condition that affects the heart and lungs. A 2017

World PH Day Toolkit with Resources, Templates and Memes

2018-04-27T15:46:42+00:00 April 27th, 2018|

Throughout May, beginning on World PH Day, May 5, 80 global pulmonary hypertension (PH) organizations will participate in a worldwide awareness campaign to advocate for access to PH diagnosis, treatment and care. Organizations will share photos, stories and social media messages linked by an image of two linked hearts, the 2018 World PH Day

Ask the Expert: Managing Seasonal Allergies in Patients With Pulmonary Hypertension (PH)

2018-04-20T14:04:36+00:00 April 20th, 2018|

By Nathan Verlinden, Cardiology Clinical Pharmacy Specialist, Allegheny General Hospital, Pittsburgh Nathan Verlinden received his PharmD from Drake University in Des Moines, Iowa, in 2013. He then completed a post-graduate year 1 (PGY-1) pharmacy practice residency at the University of Toledo Medical Center in Toledo, Ohio, followed by a PGY-2 specialty residency in cardiology at

Nadine Al-Naamani, M.D., M.S., Aldrighetti Research Award for Young Investigators Grant Recipient, Shares Research Journey and Hope for the Future

2018-04-13T14:26:59+00:00 April 11th, 2018|

Nadine Al-Naamani, M.D., M.S., University of Pennsylvania, and Andrew Sweatt, M.D., Stanford University, were the research awardees of the 2017 Aldrighetti Research Award for Young Investigators and PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension, respectively. In this two-part series, the 2017 PHA Research Program awardees detail their journey to PH, and their hopes for

Study Finds Inhaled Nitric Oxide May Benefit Patients with COPD and Pulmonary Hypertension

2018-04-11T15:26:35+00:00 April 11th, 2018|

by Phyllis Hanlon, Contributing Writer   The Centers for Disease Control and Prevention (CDC) reports that about 15.7 million people in the U.S. have been diagnosed with chronic obstructive pulmonary disease (COPD). The CDC noted in 2014 that this disease was the third leading cause of death in the U.S. Previous research has estimated that between

2017 PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension Award Grantee Discusses Work and Research

2018-04-09T19:20:14+00:00 April 6th, 2018|

Andrew Sweatt, M.D., Stanford University, and Nadine Al-Naamani, M.D., M.S., University of Pennsylvania, are the research awardees of the 2017 PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension and Aldrighetti Research Award for Young Investigators, respectively. In the first of a two-part series, Dr. Sweatt discusses his research journey, grant awarded study and involvement with the

Clinicians Explore Mindfulness as a Possible Benefit to Complement Pulmonary Hypertension Treatments

2018-04-06T14:21:26+00:00 April 6th, 2018|

Note: PHA cautions PH patients to check with their doctor before taking up yoga, meditation and other mindfulness practices. Pulmonary hypertension (PH) is a progressive disease that affects the heart and the lungs (Lai, Potoka, Champion, Mora & Gladwin, 2014). Patients with this disease are treated to help control the pulmonary pressures and prevent